Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

14.99
+0.04000.27%
Post-market: 14.990.00000.00%19:30 EDT
Volume:948.52K
Turnover:14.06M
Market Cap:803.91M
PE:-3.40
High:15.16
Open:15.05
Low:14.31
Close:14.95
52wk High:24.27
52wk Low:12.51
Shares:53.63M
Float Shares:40.15M
Volume Ratio:0.81
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4100
EPS(LYR):-5.8400
ROE:-36.27%
ROA:-18.50%
PB:1.79
PE(LYR):-2.57

Loading ...

Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 03, 2023

Major Issues Report

8-K - Current report
Jan 17, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 16, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2022

Major Issues Report

8-K - Current report